<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Both increased graft rejection and increased <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft vs host disease</z:e> (GVHD) remain obstacles to success for unrelated donor (URD) BMT for patients with SAA </plain></SENT>
<SENT sid="1" pm="."><plain>Partial T cell <z:mpath ids='MPATH_63'>depletion</z:mpath> (PTCD) may decrease the risk of severe GVHD, while still maintaining sufficient donor T lymphocytes to ensure engraftment </plain></SENT>
<SENT sid="2" pm="."><plain>We report on 12 patients with SAA who underwent PTCD URD BMT </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had failed medical therapy or relapsed following initial responses, and were transfusion dependent </plain></SENT>
<SENT sid="4" pm="."><plain>The median age was 6 years, and there were five males </plain></SENT>
<SENT sid="5" pm="."><plain>Donors were matched for four patients, and mismatched for eight </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients received total body irradiation with either Ara-C or thiotepa and <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>PTCD was accomplished using monoclonal antibody T10B9 or OKT3 and complement </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients engrafted, with a median time of 18 days to ANC &gt;500 </plain></SENT>
<SENT sid="9" pm="."><plain>Only one patient had greater than grade II <z:hpo ids='HP_0011009'>acute</z:hpo> GVHD; two patients had limited and one patient extensive <z:hpo ids='HP_0011010'>chronic</z:hpo> GVHD </plain></SENT>
<SENT sid="10" pm="."><plain>Nine patients are alive and transfusion independent at a median months post BMT </plain></SENT>
<SENT sid="11" pm="."><plain>Three patients died from <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> or <z:hpo ids='HP_0000083'>renal failure</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>This series suggests that an aggressive immunosuppressive conditioning regimen with PTCD results in successful engraftment and minimal GVHD in pediatric patients with SAA, even with HLA mismatched donors </plain></SENT>
</text></document>